EP2292617

1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors

Status:
EP einkaleyfi: Þýðing ekki lögð inn
EP appl. date:
18.5.2006
EP published:
11.7.2012
EP application number:
10175369.7

EPO information:
European Patent Register

Max expiry date:
17.5.2026

Title:
1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors

Timeline

Today

18.5.2006EP application

11.7.2012EP Publication

Owner

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, CH

Inventor

Name:
Garcia-Echeverria, Carlos
Address:
Basel, CH

Name:
Stauffer, Frédéric
Address:
Reinach, CH

Name:
Furet, Pascal
Address:
Thann, FR

Priority

Number:
0510390
Date:
20.5.2005
Country:
GB

Classification

Categories:
C07D 471/04, A61K 31/4188, A61P 35/00, A61P 29/00, A61P 11/06

Upload documents

Email *

Reference number

Click here to upload document

EP2292617

1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors

Status:

EP appl. date:

EP published:

EP application number:

EPO information:

Max expiry date:

Title:

Timeline

Owner

Name:

Address:

Inventor

Name:

Address:

Name:

Address:

Name:

Address:

Priority

Number:

Date:

Country:

Classification

Categories:

Upload documents